OpenAI, working with Molecule.one, describes a near-autonomous AI chemist that improved a difficult reaction in medicinal chemistry. The system is based on GPT-5.4 and was applied to a reaction type that matters for drug-making. According to the source, the result is an example of AI being used not just for text generation but for practical experimental research.
Because there is only one source, there are no independent findings to compare. The announcement frames the outcome as a step forward for AI-driven experimentation, though it does not include detailed performance metrics or a peer-reviewed protocol in the summary. Still, the collaboration suggests that large language models are increasingly being tested as research tools in chemistry.